nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—Progesterone—uterine cancer	0.31	1	CrCtD
Trilostane—HSD3B2—Medroxyprogesterone Acetate—uterine cancer	0.206	0.84	CbGbCtD
Trilostane—ESR2—uterine cancer	0.113	0.619	CbGaD
Trilostane—ESR1—uterine cancer	0.0699	0.381	CbGaD
Trilostane—Stanozolol—Progesterone—uterine cancer	0.0358	0.189	CrCrCtD
Trilostane—Drostanolone—Progesterone—uterine cancer	0.031	0.163	CrCrCtD
Trilostane—Oxandrolone—Progesterone—uterine cancer	0.029	0.153	CrCrCtD
Trilostane—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.0236	0.0962	CbGbCtD
Trilostane—Danazol—Progesterone—uterine cancer	0.0198	0.104	CrCrCtD
Trilostane—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.0166	0.0877	CrCrCtD
Trilostane—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0162	0.0855	CrCrCtD
Trilostane—ESR1—Progesterone—uterine cancer	0.0157	0.0638	CbGbCtD
Trilostane—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0144	0.0761	CrCrCtD
Trilostane—Methyltestosterone—Progesterone—uterine cancer	0.0141	0.0745	CrCrCtD
Trilostane—HSD3B1—corpus luteum—uterine cancer	0.0139	0.528	CbGeAlD
Trilostane—Testosterone—Progesterone—uterine cancer	0.0126	0.0664	CrCrCtD
Trilostane—ESR2—oviduct—uterine cancer	0.00124	0.0469	CbGeAlD
Trilostane—HSD3B1—decidua—uterine cancer	0.00114	0.043	CbGeAlD
Trilostane—HSD3B1—mammalian vulva—uterine cancer	0.00104	0.0395	CbGeAlD
Trilostane—HSD3B1—female reproductive system—uterine cancer	0.000893	0.0338	CbGeAlD
Trilostane—ESR1—oviduct—uterine cancer	0.000847	0.0321	CbGeAlD
Trilostane—HSD3B1—female gonad—uterine cancer	0.000812	0.0308	CbGeAlD
Trilostane—HSD3B2—female reproductive system—uterine cancer	0.000707	0.0268	CbGeAlD
Trilostane—HSD3B2—female gonad—uterine cancer	0.000644	0.0244	CbGeAlD
Trilostane—HSD3B2—lymph node—uterine cancer	0.000414	0.0157	CbGeAlD
Trilostane—ESR2—epithelium—uterine cancer	0.000311	0.0118	CbGeAlD
Trilostane—ESR2—uterine cervix—uterine cancer	0.000308	0.0117	CbGeAlD
Trilostane—ESR2—smooth muscle tissue—uterine cancer	0.000299	0.0113	CbGeAlD
Trilostane—ESR2—renal system—uterine cancer	0.000288	0.0109	CbGeAlD
Trilostane—ESR2—endometrium—uterine cancer	0.000279	0.0106	CbGeAlD
Trilostane—ESR1—myometrium—uterine cancer	0.000271	0.0103	CbGeAlD
Trilostane—ESR2—uterus—uterine cancer	0.000257	0.00973	CbGeAlD
Trilostane—Danazol—CCL2—uterine cancer	0.000243	0.19	CrCbGaD
Trilostane—ESR2—female reproductive system—uterine cancer	0.000231	0.00875	CbGeAlD
Trilostane—HSD3B2—Corticotropin-releasing hormone—CYP11A1—uterine cancer	0.000216	0.00496	CbGpPWpGaD
Trilostane—ESR1—epithelium—uterine cancer	0.000213	0.00806	CbGeAlD
Trilostane—ESR1—uterine cervix—uterine cancer	0.000211	0.00799	CbGeAlD
Trilostane—ESR2—female gonad—uterine cancer	0.00021	0.00796	CbGeAlD
Trilostane—ESR2—Ovarian Infertility Genes—PGR—uterine cancer	0.00021	0.00482	CbGpPWpGaD
Trilostane—ESR2—vagina—uterine cancer	0.000209	0.00791	CbGeAlD
Trilostane—ESR1—smooth muscle tissue—uterine cancer	0.000205	0.00777	CbGeAlD
Trilostane—ESR1—decidua—uterine cancer	0.000201	0.00762	CbGeAlD
Trilostane—ESR1—renal system—uterine cancer	0.000197	0.00748	CbGeAlD
Trilostane—ESR1—endometrium—uterine cancer	0.000191	0.00723	CbGeAlD
Trilostane—Drostanolone—CYP19A1—uterine cancer	0.000188	0.147	CrCbGaD
Trilostane—ESR2—Nuclear Receptors—PGR—uterine cancer	0.000183	0.0042	CbGpPWpGaD
Trilostane—ESR1—uterus—uterine cancer	0.000176	0.00666	CbGeAlD
Trilostane—ESR2—Ovarian Infertility Genes—CYP19A1—uterine cancer	0.000168	0.00385	CbGpPWpGaD
Trilostane—ESR1—female reproductive system—uterine cancer	0.000158	0.00599	CbGeAlD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000153	0.00352	CbGpPWpGaD
Trilostane—Danazol—PGR—uterine cancer	0.000148	0.116	CrCbGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.000144	0.00332	CbGpPWpGaD
Trilostane—ESR1—female gonad—uterine cancer	0.000144	0.00545	CbGeAlD
Trilostane—ESR1—vagina—uterine cancer	0.000143	0.00542	CbGeAlD
Trilostane—ESR2—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000137	0.00315	CbGpPWpGaD
Trilostane—ESR2—lymph node—uterine cancer	0.000135	0.00512	CbGeAlD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.000133	0.00306	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	0.00012	0.00277	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	0.00012	0.00275	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000116	0.00267	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000111	0.00254	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000111	0.00254	CbGpPWpGaD
Trilostane—Danazol—CYP19A1—uterine cancer	0.000102	0.0793	CrCbGaD
Trilostane—ESR2—Nuclear Receptors—ESR1—uterine cancer	9.76e-05	0.00224	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—CXCL8—uterine cancer	9.75e-05	0.00224	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	9.7e-05	0.00223	CbGpPWpGaD
Trilostane—Testosterone—CYP11A1—uterine cancer	9.62e-05	0.0751	CrCbGaD
Trilostane—Danazol—ESR1—uterine cancer	9.34e-05	0.0729	CrCbGaD
Trilostane—Estradiol—ESR2—uterine cancer	9.27e-05	0.0723	CrCbGaD
Trilostane—ESR1—lymph node—uterine cancer	9.25e-05	0.0035	CbGeAlD
Trilostane—ESR1—Nuclear Receptors—PGR—uterine cancer	9.22e-05	0.00212	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—ESR1—uterine cancer	9.18e-05	0.00211	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—PGR—uterine cancer	9.03e-05	0.00207	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—CTNNB1—uterine cancer	8.99e-05	0.00206	CbGpPWpGaD
Trilostane—ESR1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	8.79e-05	0.00202	CbGpPWpGaD
Trilostane—Methyltestosterone—CYP19A1—uterine cancer	8.58e-05	0.067	CrCbGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.4e-05	0.00193	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.4e-05	0.00193	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.14e-05	0.00187	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—ESR2—uterine cancer	8.12e-05	0.00186	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—YWHAE—uterine cancer	7.97e-05	0.00183	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptor transcription pathway—ESR1—uterine cancer	7.71e-05	0.00177	CbGpPWpGaD
Trilostane—Progesterone—PGR—uterine cancer	7.67e-05	0.0599	CrCbGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—ESR2—uterine cancer	7.64e-05	0.00175	CbGpPWpGaD
Trilostane—ESR2—Ovarian Infertility Genes—CDKN1B—uterine cancer	7.61e-05	0.00175	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	7.44e-05	0.00171	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—CXCL8—uterine cancer	7.39e-05	0.0017	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PGR—uterine cancer	7.28e-05	0.00167	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SRD5A2—uterine cancer	6.83e-05	0.00157	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NDUFB11—uterine cancer	6.83e-05	0.00157	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—CTNNB1—uterine cancer	6.81e-05	0.00156	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	6.71e-05	0.00154	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—STK11—uterine cancer	6.68e-05	0.00153	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.63e-05	0.00152	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—ESR1—uterine cancer	6.43e-05	0.00148	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	6.41e-05	0.00147	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.26e-05	0.00144	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.17e-05	0.00142	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	6.07e-05	0.00139	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	6.04e-05	0.00139	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—IRF1—uterine cancer	5.91e-05	0.00136	CbGpPWpGaD
Trilostane—Estradiol—ESR1—uterine cancer	5.71e-05	0.0446	CrCbGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—YWHAE—uterine cancer	5.63e-05	0.00129	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—YWHAE—uterine cancer	5.52e-05	0.00127	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	5.35e-05	0.00123	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—BIRC5—uterine cancer	5.26e-05	0.00121	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NDUFB11—uterine cancer	5.17e-05	0.00119	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SRD5A2—uterine cancer	5.17e-05	0.00119	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	5.13e-05	0.00118	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—AKT1—uterine cancer	5.05e-05	0.00116	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.03e-05	0.00115	CbGpPWpGaD
Trilostane—Testosterone—CYP19A1—uterine cancer	4.98e-05	0.0388	CrCbGaD
Trilostane—HSD3B1—Metabolism—AKR1B1—uterine cancer	4.94e-05	0.00113	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—STAR—uterine cancer	4.94e-05	0.00113	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.88e-05	0.00112	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—SOCS3—uterine cancer	4.85e-05	0.00111	CbGpPWpGaD
Trilostane—Progesterone—ESR1—uterine cancer	4.84e-05	0.0378	CrCbGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	4.77e-05	0.0011	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.75e-05	0.00109	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	4.41e-05	0.00101	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	4.41e-05	0.00101	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	4.06e-05	0.000931	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	4.02e-05	0.000922	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—SOCS3—uterine cancer	4.01e-05	0.00092	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—POLD1—uterine cancer	3.87e-05	0.000889	CbGpPWpGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	3.84e-05	0.000881	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—AKT1—uterine cancer	3.83e-05	0.000879	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—SMAD3—uterine cancer	3.79e-05	0.000869	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	3.75e-05	0.000861	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	3.75e-05	0.000861	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—STAR—uterine cancer	3.74e-05	0.000859	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKR1B1—uterine cancer	3.74e-05	0.000859	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.7e-05	0.000849	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKR1C1—uterine cancer	3.62e-05	0.000832	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	3.61e-05	0.000828	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.6e-05	0.000826	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	3.58e-05	0.000821	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—CDKN2A—uterine cancer	3.49e-05	0.000801	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PHF1—uterine cancer	3.39e-05	0.000777	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	3.31e-05	0.000761	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	3.29e-05	0.000756	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	3.25e-05	0.000746	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—RRM2—uterine cancer	3.23e-05	0.000741	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—DCN—uterine cancer	3.14e-05	0.00072	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PGR—uterine cancer	3.04e-05	0.000698	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	2.98e-05	0.000683	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP11A1—uterine cancer	2.95e-05	0.000678	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—POLD1—uterine cancer	2.94e-05	0.000674	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—CHD4—uterine cancer	2.88e-05	0.000661	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	2.87e-05	0.000659	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKR1C3—uterine cancer	2.79e-05	0.00064	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKR1C1—uterine cancer	2.75e-05	0.00063	CbGpPWpGaD
Trilostane—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	2.71e-05	0.000623	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.68e-05	0.000616	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	2.66e-05	0.00061	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	2.65e-05	0.000609	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	2.61e-05	0.0006	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	2.59e-05	0.000594	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	2.52e-05	0.000579	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PGR—uterine cancer	2.5e-05	0.000573	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—RRM2—uterine cancer	2.45e-05	0.000562	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	2.44e-05	0.000561	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	2.44e-05	0.000561	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SUZ12—uterine cancer	2.41e-05	0.000554	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	2.41e-05	0.000553	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.41e-05	0.000552	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.39e-05	0.000548	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—DCN—uterine cancer	2.38e-05	0.000545	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.36e-05	0.000542	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	2.32e-05	0.000532	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	2.25e-05	0.000515	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP11A1—uterine cancer	2.24e-05	0.000514	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.23e-05	0.000512	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	2.23e-05	0.000511	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	2.2e-05	0.000504	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP19A1—uterine cancer	2.17e-05	0.000499	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—STK11—uterine cancer	2.17e-05	0.000499	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKR1C3—uterine cancer	2.11e-05	0.000485	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	2.1e-05	0.000482	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	2.1e-05	0.000482	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	2.1e-05	0.000481	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	2.07e-05	0.000474	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	2.05e-05	0.000471	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	2.05e-05	0.00047	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.04e-05	0.000468	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.03e-05	0.000466	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	2.03e-05	0.000465	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.02e-05	0.000465	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.97e-05	0.000452	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.95e-05	0.000447	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	1.94e-05	0.000445	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	1.94e-05	0.000444	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—uterine cancer	1.9e-05	0.000437	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	1.9e-05	0.000436	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	1.89e-05	0.000434	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	1.89e-05	0.000434	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—EP300—uterine cancer	1.88e-05	0.000432	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.82e-05	0.000419	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.82e-05	0.000417	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—EP300—uterine cancer	1.8e-05	0.000414	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—CDKN2B—uterine cancer	1.79e-05	0.000411	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.78e-05	0.000409	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.73e-05	0.000396	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.72e-05	0.000395	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PHF1—uterine cancer	1.71e-05	0.000392	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.68e-05	0.000385	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	1.67e-05	0.000384	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP19A1—uterine cancer	1.65e-05	0.000378	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—STK11—uterine cancer	1.65e-05	0.000378	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—uterine cancer	1.63e-05	0.000375	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—SMAD3—uterine cancer	1.63e-05	0.000375	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.6e-05	0.000368	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.6e-05	0.000368	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.55e-05	0.000355	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.52e-05	0.000348	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.47e-05	0.000338	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—CHD4—uterine cancer	1.45e-05	0.000333	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.44e-05	0.00033	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	1.42e-05	0.000326	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—ESR1—uterine cancer	1.33e-05	0.000306	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—uterine cancer	1.29e-05	0.000296	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.29e-05	0.000296	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PGR—uterine cancer	1.26e-05	0.000289	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—uterine cancer	1.24e-05	0.000284	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SUZ12—uterine cancer	1.22e-05	0.000279	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PGR—uterine cancer	1.2e-05	0.000276	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	1.19e-05	0.000274	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.18e-05	0.000272	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—HRAS—uterine cancer	1.17e-05	0.000268	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.15e-05	0.000263	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—EZH2—uterine cancer	1.14e-05	0.000262	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—uterine cancer	1.11e-05	0.000256	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	1.11e-05	0.000254	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	1.1e-05	0.000253	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.09e-05	0.00025	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.05e-05	0.000241	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—uterine cancer	1.03e-05	0.000237	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.02e-05	0.000235	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PTEN—uterine cancer	1.02e-05	0.000233	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	9.93e-06	0.000228	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	9.74e-06	0.000224	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	9.69e-06	0.000222	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	9.67e-06	0.000222	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	9.23e-06	0.000212	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	9.19e-06	0.000211	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTEN—uterine cancer	9.08e-06	0.000209	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NRAS—uterine cancer	9.07e-06	0.000208	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	9.02e-06	0.000207	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	8.68e-06	0.000199	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—EP300—uterine cancer	8.66e-06	0.000199	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—CDKN2B—uterine cancer	8.61e-06	0.000198	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	8.46e-06	0.000194	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	8.23e-06	0.000189	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.07e-06	0.000185	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—SMAD3—uterine cancer	7.86e-06	0.00018	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	7.84e-06	0.00018	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—KRAS—uterine cancer	7.8e-06	0.000179	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKR1B10—uterine cancer	7.69e-06	0.000177	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	7.65e-06	0.000176	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	7.17e-06	0.000165	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	6.97e-06	0.00016	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTEN—uterine cancer	6.88e-06	0.000158	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—HRAS—uterine cancer	6.63e-06	0.000152	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—EP300—uterine cancer	6.57e-06	0.000151	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	6.5e-06	0.000149	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ESR1—uterine cancer	6.41e-06	0.000147	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3CA—uterine cancer	6.41e-06	0.000147	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—RNF43—uterine cancer	6.38e-06	0.000146	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PGR—uterine cancer	6.06e-06	0.000139	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	5.97e-06	0.000137	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	5.89e-06	0.000135	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—uterine cancer	5.86e-06	0.000134	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INHBA—uterine cancer	5.83e-06	0.000134	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.78e-06	0.000133	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—EZH2—uterine cancer	5.75e-06	0.000132	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ESR2—uterine cancer	5.33e-06	0.000122	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKR1C1—uterine cancer	5.25e-06	0.000121	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—uterine cancer	5.24e-06	0.00012	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.88e-06	0.000112	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3CA—uterine cancer	4.86e-06	0.000112	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—CDKN2B—uterine cancer	4.34e-06	9.97e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKR1C3—uterine cancer	4.04e-06	9.28e-05	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—uterine cancer	3.97e-06	9.11e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—SMAD3—uterine cancer	3.96e-06	9.1e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PGR—uterine cancer	3.94e-06	9.04e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—YWHAE—uterine cancer	3.76e-06	8.63e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FBXW7—uterine cancer	3.6e-06	8.27e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—STK11—uterine cancer	3.15e-06	7.23e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SOCS3—uterine cancer	2.95e-06	6.77e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CDKN2B—uterine cancer	2.82e-06	6.48e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1R—uterine cancer	2.74e-06	6.29e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SMAD3—uterine cancer	2.58e-06	5.92e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—FGFR2—uterine cancer	2.46e-06	5.64e-05	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—uterine cancer	2.31e-06	5.31e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL2—uterine cancer	1.85e-06	4.25e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ERBB2—uterine cancer	1.54e-06	3.54e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CXCL8—uterine cancer	1.46e-06	3.36e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CDKN1B—uterine cancer	1.43e-06	3.28e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CTNNB1—uterine cancer	1.35e-06	3.1e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTEN—uterine cancer	1.32e-06	3.02e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—EP300—uterine cancer	1.26e-06	2.88e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VEGFA—uterine cancer	1.19e-06	2.73e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NRAS—uterine cancer	1.17e-06	2.7e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—uterine cancer	1.17e-06	2.68e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—KRAS—uterine cancer	1.01e-06	2.32e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PIK3CA—uterine cancer	9.29e-07	2.13e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—uterine cancer	8.98e-07	2.06e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HRAS—uterine cancer	8.59e-07	1.97e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—uterine cancer	7.59e-07	1.74e-05	CbGpPWpGaD
